This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The life sciences landscape is moving at a rapid pace, which in turn is increasing the demands on marketers to create innovative, digital content faster while maintaining industry compliance. Veeva Systems recently conducted an annual industry study, focused on content and digital asset management within life sciences. Gleaned from the experiences and opinions of leaders across the life sciences industry, the research uncovers current practices and the industry’s need for more advanced approache
When I was a student in pharmacy school, one of our earliest assignments was the so-called 'JellyBean Experiment,' whereby students were assigned a longitudinal project in which they were to mimic a patient with a chronic condition treated with medications. The assignment is aimed to help students understand the pill burden that patients face on a daily basis, and in my mind, bring in a better empathetic understanding towards nonadherence and how to talk about it.
Hypertension management can get a little overwhelming sometimes since there are so many medications to choose from. We often use multiple medications with different mechanisms of action to treat hypertension. If a patient is already on a medication at a moderate or low dose, what should we do if blood pressure remains elevated? I’m going […].
Over the past few years there has been a shift in the European pharmaceutical market landscape, with a rise in specialty medicines for diseases with narrow patient populations. Indeed, QuintilesIMS forecasts that, between 2013 and 2018, 94% of list price value growth will be in specialty medicines – with orphan drugs at the forefront of this trend. On 10 April 2017, QuintilesIMS, in partnership with pharmaphorum presents a unique digital debate, bringing together a panel of senior industry exper
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Patient reports increasing swelling, sedation, and has complaints of being dizzy. She has been having worsening urinary incontinence which has been classified as stress incontinence. She was recently discontinued off her Enablex as she felt it did not work. Gabapentin apparently has not been effective for her neuropathy per her report. Her current medications include; […].
I received this guest post from Kyle Roberts! It does a really nice job of demonstrating the challenges and potential risks with fentanyl and opioids in general. If you’d like to share a case with a story, please feel free to contact me! An elderly female was on a maintenance opioid regimen of Morphine ER […]. The post Fentanyl Patch Overdose – Case Scenario appeared first on Med Ed 101.
How to Negotiate a Raise for Obtaining Pharmacy Certifications By Alex Barker, Pharm.D Most pharmacists know that there are a wide range of pharmacy certifications available, including the Board Certified Geriatric Pharmacist (BCGP) – formerly called CGP, Board Certified Pharmacotherapy Specialist (BCPS), Board Certified Ambulatory Care Pharmacists (BCACP) and others based on specialty area.
40
40
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
How to Negotiate a Raise for Obtaining Pharmacy Certifications By Alex Barker, Pharm.D Most pharmacists know that there are a wide range of pharmacy certifications available, including the Board Certified Geriatric Pharmacist (BCGP) – formerly called CGP, Board Certified Pharmacotherapy Specialist (BCPS), Board Certified Ambulatory Care Pharmacists (BCACP) and others based on specialty area.
What to do with antiplatelet medications in the setting of anemia has always been a huge challenge for me. Here’s a scenario with some questions to think about. A 64 year old female has a history of CAD, hyperlipidemia, hypertension, CABG, depression, anemia, osteoarthritis, and constipation. Current meds include: Lisinopril 5 mg daily Clopidogrel 75 […].
Assessment of medication and goals of therapy need to be continually monitored. In this scenario, I pick out a few medications that should be looked in consideration of age and goals of reducing medication burden. A 98 year old female is on the following medications. Lipitor 10 mg daily Amlodipine 10 mg daily Diovan/HCTZ 160/12.5 […]. The post Reducing Medication Burden – Age and Goals of Therapy are Important appeared first on Med Ed 101.
Just like anything, long term care has its own language. I’m going to breakdown a few of the most important acronyms and terminology that any consultant pharmacist in long term care should know. DRR or MRR. Drug regimen review (or medication regimen review) is the primary component of what a consultant pharmacist does on at […]. The post Must Know Terminology for the Long Term Care Consultant Pharmacist appeared first on Med Ed 101.
With the help of 4 pharmacists (3 BCPS certified), I’m excited to share some BCPS Tips on Bioterrorism from my latest 300+ page creation: BCPS Bullets – I also wanted to say thanks to all who purchased it! You guys all made it high #1 in the pharmacy category (surpassing the Nursing Drug Handbook for a period […]. The post BCPS Tips – Bioterrorism appeared first on Med Ed 101.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content